Get the Stockscreener App
0.3475
18.16%
0.0534
After Hours:
.35
0.0025
+0.72%
23 Andme Holding Co stock is traded at $0.3475, with a volume of 8.52M.
It is up +18.16% in the last 24 hours and up +10.35% over the past month.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
See More
Previous Close:
$0.2941
Open:
$0.3084
24h Volume:
8.52M
Relative Volume:
2.53
Market Cap:
$175.84M
Revenue:
$247.99M
Net Income/Loss:
$-521.97M
P/E Ratio:
-0.4826
EPS:
-0.72
Net Cash Flow:
$-194.28M
1W Performance:
+2.54%
1M Performance:
+10.35%
6M Performance:
-34.68%
1Y Performance:
-64.46%
1-Day Range:
$0.2961
$0.3594
1-Week Range:
$0.294
$0.3594
52-Week Range:
$0.29
$1.02
23 Andme Holding Co Stock (ME) Company Profile
Name
23 Andme Holding Co
Sector
Industry
Phone
(650) 938-6300
Address
349 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-22 | Initiated | Berenberg | Buy |
| Sep-22-22 | Initiated | Cowen | Outperform |
| Nov-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Jul-12-21 | Initiated | Citigroup | Buy |
23 Andme Holding Co Stock (ME) Latest News
23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows - Reuters
Could 23andMe $30 million data breach settlement get derailed by mass arbitration? - Reuters
ME INVESTOR UPDATE: Shareholders of 23andMe Holding Co. are - GlobeNewswire
ME INVESTOR UPDATE: Shareholders of 23andMe Holding Co. are Alerted of Pending Investigation into the Company; Contact BFA Law if You Own Substantial Shares (Nasdaq:ME) - GlobeNewswire Inc.
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - MSN
23andMe Comments on Emotional Eating - Baystreet.ca
23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating - GlobeNewswire
23andMe Holding Co. (ME) Launches New Genetic Report on Likelihood of Frequent Emotional Eating - StreetInsider.com
23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating - Yahoo Finance
Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co. - EIN News
23andMe Board Quits As CEO Of DNA Testing Company Plans To Go Private - Yahoo Finance
Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co. - StockTitan
ME INVESTIGATION NOTICE: 23andMe Holding Co.’s Board of - GlobeNewswire
ME INVESTOR UPDATE: 23andMe Shareholders are Notified to - GlobeNewswire
ME INVESTOR UPDATE: 23andMe Shareholders are Notified to Contact BFA Law about Ongoing Investigation into the Company for Breaches of Fiduciary Duties (Nasdaq:ME) - GlobeNewswire Inc.
23andMe’s stock tumbles 7% after independent directors quit in clash with CEO over buyout plan - MSN
What happened to 23andMe? - CNN
Every single member of the board just resigned from DNA tester 23andMe - Yahoo Finance
23andMe directors resign as the CEO of the genetic-testing company seeks to take it private - Yahoo Finance
23andMe to pay $30M to settle data breach lawsuit - MSN
Board Members Resign En Masse at 23andMe (NASDAQ:ME) - MSN
Wolf Popper LLP is Investigating Whether the Offer to - GlobeNewswire
23andMe faces potential Nasdaq delisting By Investing.com - Investing.com Australia
ME STOCK ALERT: 23andMe Holding Co. Shareholders are Notified that an Investigation has been Initiated Against the Company’s Board of Directors and are Urged to Contact BFA Law (NASDAQ:ME) - GlobeNewswire
23andMe faces potential Nasdaq delisting By Investing.com - Investing.com Canada
23andMe faces potential Nasdaq delisting - Investing.com India
23andMe faces potential Nasdaq delisting - Investing.com
Board Members Resign En Masse at 23andMe (NASDAQ:ME) - TipRanks
23andMe faces potential Nasdaq delisting By Investing.com - Investing.com UK
23andMe Holding (ME) no longer in compliance with Nasdaq listing rules - StreetInsider.com
7 of 8 Directors Resign From 23AndMe in Clash With CEO - Law360
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time - AOL
23andMe independent board directors resign en masse, rebuking Anne Wojcicki's takeover plan - Axios
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time - Yahoo Finance
Mass Resignation at 23andMe Amid Strategic Disagreements - TipRanks
23andMe’s stock tumbles 7% after independent directors quit in clash with CEO over buyout plan - MarketWatch
23andMe board members resign over strategic differences - Investing.com India
23andMe’s independent directors quit in clash with CEO over buyout plan - MarketWatch
23andMe CEO Anne Wojcicki Reaffirms Commitment to Taking Company Private After Board Resignations - CEOWORLD magazine
23andMe board members resign over strategic differences By Investing.com - Investing.com Canada
23andMe Directors Quit Over CEO's Lowball Takeover Offer - Finimize
23andMe’s Wojcicki Says She Still Wants to Take Company Private - Bloomberg
23andMe board members resign over strategic differences - Investing.com
23andMe independent directors quit board over unsatisfactory buyout plan from CEO - Marketscreener.com
23andMe independent directors resign due to no proposal from Wojcicki - Seeking Alpha
23andMe board members resign over strategic differences By Investing.com - Investing.com UK
Independent Directors of 23andMe Resign from Board - GlobeNewswire
Independent Directors of 23andMe Resign from Board - StockTitan
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - BNN Bloomberg
23andMe agrees to pay $30M to settle lawsuit over 2023 data breach - Fox Business
Citi cautious on 23andMe stock as early data and takeover bids emerge - Investing.com Canada
23 Andme Holding Co Stock (ME) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):